Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
555.00    1.00 (0.18%)
Bid:
555.00
Ask:
555.50
Spread: 0.50 (0.09%)
Market Cap: £2.46b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Directorate Change

9 May 2019 11:00

RNS Number : 5090Y
Tate & Lyle PLC
09 May 2019
Β 

9 May 2019

Β 

Tate & Lyle PLC

Β 

Β 

BOARD CHANGES

Β 

Tate & Lyle PLC (the "Company") announces that Kimberly (Kim) Nelson will join the Board as a non-executive director and a member of the Audit and Nominations Committees on 1 July 2019. Kim brings extensive experience and knowledge of the food and beverage industry to the Board having worked for General Mills Inc. for nearly 30 years. During her career at General Mills, she held a number of senior brand and general management roles before becoming Senior Vice President, External Relations in 2010. Kim retired from General Mills Inc. in 2018. She is a US citizen.

Β 

The following changes to the Board and Board Committees will take effect at the conclusion of the Company's AGM on 25 July 2019:

Β 

Board

Β· Douglas Hurt will retire from the Board, having served as a non-executive director since March 2010, as the Chair of the Audit Committee since March 2015 and as Senior Independent Director since January 2017.

Β· Warren Tucker is appointed as Chair of the Audit Committee.

Β· Paul Forman is appointed as Senior Independent Director.

Β 

Board Committees

Β· Dr Ajai Puri will step down from the Remuneration Committee and join the Audit Committee.

Β· Sybella Stanley will step down from the Audit Committee and join the Remuneration Committee.

Β· Paul Forman will step down from the Remuneration Committee.

Β 

Dr Gerry Murphy, Chairman of Tate & Lyle, said: "I am delighted that Kim has agreed to join the Board. Her appointment recognises the importance of the US to Tate & Lyle, in terms of our customers, operations and employees. Her substantial experience in the food and beverage industry will be of significant benefit to the Board."

Β 

"I would like to thank Douglas Hurt for his nine years of outstanding service and significant contribution to the Board and, in particular, for his time served as Chairman of the Audit Committee and as Senior Independent Director."

Β 

There are no further disclosures to be made in connection with Ms Nelson's appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority's Listing Rules.

Β 

Β 

For more information contact Tate & Lyle PLC:

Christopher Marsh, Group VP, Investor Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688

Β 

Andrew Lorenz (FTI Consulting), Media Relations

Tel: +44 (0) 20 7269 7113 or Mobile: +44 (0) 7775 641 807

Β 

Β 

About Tate & Lyle:Β Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants). It also sells co-products from the corn milling process as animal nutrition.Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2018, Tate & Lyle sales totalled Β£2.7Β billion. For more information, please visitΒ http://www.tateandlyle.com

Β 

Β 

Claire-Marie O'Grady

Company Secretary

Tate & Lyle PLC

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOASSASUUFUSESI
Date   Source Headline
10th Sep 20245:42 pmRNSTransaction in Own Shares
9th Sep 20245:27 pmRNSTransaction in Own Shares
9th Sep 202411:00 amRNSHolding(s) in Company
6th Sep 20245:47 pmRNSTransaction in Own Shares
5th Sep 20245:47 pmRNSTransaction in Own Shares
5th Sep 20241:00 pmRNSHolding(s) in Company
4th Sep 20245:58 pmRNSTransaction in Own Shares
3rd Sep 20245:33 pmRNSTransaction in Own Shares
2nd Sep 20245:44 pmRNSTransaction in Own Shares
2nd Sep 20245:00 pmRNSTotal Voting Rights
30th Aug 20245:39 pmRNSTransaction in Own Shares
29th Aug 20245:26 pmRNSTransaction in Own Shares
28th Aug 20245:27 pmRNSTransaction in Own Shares
27th Aug 20245:34 pmRNSTransaction in Own Shares
23rd Aug 20245:49 pmRNSTransaction in Own Shares
22nd Aug 20245:45 pmRNSTransaction in Own Shares
22nd Aug 20244:00 pmRNSDirector/PDMR Shareholding
21st Aug 20246:00 pmRNSTransaction in Own Shares
20th Aug 20245:56 pmRNSTransaction in Own Shares
19th Aug 20245:44 pmRNSTransaction in Own Shares
16th Aug 20245:50 pmRNSTransaction in Own Shares
15th Aug 20245:57 pmRNSTransaction in Own Shares
14th Aug 20245:46 pmRNSTransaction in Own Shares
13th Aug 20245:54 pmRNSTransaction in Own Shares
13th Aug 20247:00 amRNSDirectorate Change
12th Aug 20245:43 pmRNSTransaction in Own Shares
9th Aug 20245:23 pmRNSTransaction in Own Shares
8th Aug 20245:50 pmRNSTransaction in Own Shares
8th Aug 20244:00 pmRNSDirector/PDMR Shareholding
7th Aug 20245:34 pmRNSTransaction in Own Shares
7th Aug 20244:05 pmRNSNotification of transactions by PDMRs
6th Aug 20245:29 pmRNSTransaction in Own Shares
5th Aug 20245:35 pmRNSTransaction in Own Shares
2nd Aug 20245:46 pmRNSTransaction in Own Shares
1st Aug 20245:28 pmRNSTransaction in Own Shares
1st Aug 20242:30 pmRNSTotal Voting Rights
31st Jul 20245:15 pmRNSTransaction in Own Shares
30th Jul 20245:23 pmRNSTransaction in Own Shares
29th Jul 20245:34 pmRNSTransaction in Own Shares
29th Jul 20242:00 pmRNSCompany Secretary Change
26th Jul 20245:33 pmRNSTransaction in Own Shares
25th Jul 20245:28 pmRNSTransaction in Own Shares
25th Jul 20242:00 pmRNSResult of AGM
25th Jul 20247:00 amRNSTrading Statement
24th Jul 20245:24 pmRNSTransaction in Own Shares
24th Jul 20245:15 pmRNSTotal Voting Rights
23rd Jul 20245:40 pmRNSTransaction in Own Shares
22nd Jul 20245:26 pmRNSTransaction in Own Shares
19th Jul 20245:33 pmRNSTransaction in Own Shares
18th Jul 20245:37 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.